PIM1 and Miyoshi myopathy: Pims make up a group of serine/threonine kinases that act to regulate and express cell cycle progression and survival.44 Elevated levels of Pim1 and 2 have been found across all hematological malignancies, specifically in MM with the highest level of Pim-2 expression, making it an ideal target for anticancer therapy.